Lee Eunji, Yoon Sang-Hoon, Kim Hyunho, Kim Young Doo, Leem Jungtae, Park Jinbong
Chung-Yeon Korean Medicine Hospital, Gwangju, Republic of Korea.
Chung-Yeon Central Institute, Gwangju, Republic of Korea.
Integr Med Res. 2020 Jun;9(2):100408. doi: 10.1016/j.imr.2020.100408. Epub 2020 Mar 29.
Ephedrae Herba is widely used to treat obesity. There is a concern for adverse events (AEs) using it and we need to develop strategies to attenuate it without its effectiveness for weight-reducing potential. We investigated the effects of a combination of Ephedra Herba with Zhizichi decoction and Phellodendri Cortex (Anmyungambi (AMGB) decoction) in reducing the incidence of Ephedra Herba-related AEs.
We performed a retrospective chart review from a clinical case series of patients visiting the Jaonmi Korean Medicine Clinic (Seoul, Korea). The inclusion criteria was patients who were prescribed AMGB decoction, (containing Ephedrae Herba, Phellodendri Cortex, and Zhizichi decoction [Gardeniae Fructus, and Glycine Semen Preparata] in different proportions) for weight reduction. Exclusion of Phellodendri Cortex in the original AMGB preparation was allowed; conventional medications, acupuncture, and dietary supplements were not allowed. The primary outcome was absolute weight loss at the end of treatment.
Twenty-seven patients (6 men and 21 women), aged 18-75 years (mean age, 42.6 ± 11.1 years) and the average treatment duration was 39.4 days. Absolute weight loss at the end of treatment was 4.49 ± 2.40 kg. Fifteen patients lost more than 5% weight (55.6%). Treatment >45 days resulted in significantly greater weight loss compared to treatment <30 days ( < 0.001). Not severe AEs were reported in 16 patients including constipation, fatigue, etc.
A combination of Ephedra Herba with Zhizichi decoction and Phellodendri Cortex may be a safe and effective treatment for weight reduction in obese and overweight patients.
麻黄广泛用于治疗肥胖症。使用麻黄存在不良事件(AE)的担忧,我们需要制定策略来减轻不良事件,同时不影响其减肥潜力。我们研究了麻黄与枳实汤和黄柏(安明甘比(AMGB)汤)联合使用对降低麻黄相关不良事件发生率的影响。
我们对在韩国首尔朝美韩医诊所就诊的患者临床病例系列进行了回顾性病历审查。纳入标准为因减肥而服用AMGB汤(含有不同比例的麻黄、黄柏和枳实汤[栀子和炒白扁豆])的患者。允许在原AMGB制剂中排除黄柏;不允许使用常规药物、针灸和膳食补充剂。主要结局是治疗结束时的绝对体重减轻。
27例患者(6例男性和21例女性),年龄18 - 75岁(平均年龄42.6±11.1岁),平均治疗时间为39.4天。治疗结束时的绝对体重减轻为4.49±2.40千克。15例患者体重减轻超过5%(55.6%)。与治疗<30天相比,治疗>45天导致体重减轻显著更大(<0.001)。16例患者报告了不严重的不良事件,包括便秘、疲劳等。
麻黄与枳实汤和黄柏联合使用可能是肥胖和超重患者减肥的安全有效治疗方法。